By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



4 rue Pierre Fontaine

  Evry Cedex    France
Phone: 33-0-1-80-85-60-83 Fax: 33-0-1-80-85-60-87


Company News
InnaVirVax And FIT Biotech Enter Into Alliance In Functional Cure For HIV 12/21/2016 9:20:14 AM
InnaVirVax Strengthens U.S. Management And Presence 11/4/2016 10:24:55 AM
InnaVirVax Presents Highly Encouraging Results Of Its First Clinical Study On VAC-3S Immunotherapy For HIV 7/20/2015 11:21:34 AM
InnaVirVax Raises €3.6 Million In Its Third Funding Round 7/17/2015 8:22:38 AM
InnaVirVax: Bpifrance Provides Funding For The PROTHEVIH Program On The Therapeutic Vaccine VAC-3S 4/29/2014 6:34:03 AM
InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used In Combination With Standard Antiretroviral Therapy In Treatment Of HIV-Infection 12/2/2013 11:23:28 AM
InnaVirVax Announces Presentation of the Results of Its Phase I/IIa Clinical Study at CROI 2013 in Atlanta 3/5/2013 2:59:22 PM
InnaVirVax Announces Publication of an Article in JAIDS (Journal of Acquired Immune Deficiency Syndromes) 3/1/2013 11:41:12 AM
InnaVirVax: the Phase I/IIa Clinical Study of Its VAC-3S Immunotherapeutic Vaccine in the Treatment of HIV Infection Has Achieved Its Primary Endpoint 11/30/2012 1:41:55 PM
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy 6/18/2012 11:46:37 AM